About Us
|
contact Us
|
Sitemap
Call us: +1-855-455-8662
|
Home
Business Solutions
Business Research Reports
Business Consulting
On-site Implementation & Training Programs
Industry Trackers
Subscription Solutions
Industry Reports
News
Press
Login
Register
Home
Market Research
Peptide Therapeutics Market Set to Reach US$ 45,542.8 Mn by 2024
Peptide Therapeutics Market By Technology (Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), Hybrid Phase Peptide Synthesis (HPPS)), By Delivery Route (Oral Route, Parenteral Route, Pulmonary Route, Mucosal Route), By Applications (Cancer, Cardiovascular Diseases, Metabolic Diseases, Central Nervous System, Infectious Diseases, Gastrointestinal Diseases, Renal Disorders) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2024
27 Feb 2017
Format
Request Sample
Report Summary
Table of contents
list of tables
list of figures
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Peptide Therapeutics Market
2.2. Global Peptide Therapeutics Market, By Technology, 2023 (US$ Million)
2.3. Global Peptide Therapeutics Market, By Delivery Route, 2023 (US$ Million)
2.4. Global Peptide Therapeutics Market, By Applications, 2023 (US$ Million)
2.5. Global Peptide Therapeutics Market, By Geography, 2023 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2023
3. Peptide Therapeutics Market: Competitive Analysis
3.1. Market Positioning of Key Peptide Therapeutics Market Vendors
3.2. Strategies Adopted by Peptide Therapeutics Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2032
4. Peptide Therapeutics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Peptide Therapeutics Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape
5. Peptide Therapeutics Market: By Technology, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Solid Phase Peptide Synthesis (SPPS)
5.3.2. Liquid Phase Peptide Synthesis (LPPS)
5.3.3. Hybrid Phase Peptide Synthesis (HPPS)
6. Peptide Therapeutics Market: By Delivery Route, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Oral Route
6.3.2. Parenteral Route
6.3.3. Pulmonary Route
6.3.4. Mucosal Route
6.3.5. Other Routes (Intradermal & Nasal)
7. Peptide Therapeutics Market: By Applications, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
7.3.1. Cancer
7.3.2. Cardiovascular Diseases
7.3.3. Metabolic Diseases
7.3.4. Central Nervous System
7.3.5. Infectious Diseases
7.3.6. Gastrointestinal Diseases
7.3.7. Renal Disorders
7.3.8. Others (Pain Management, Dermatological Disorders, and Hematological Disorders)
8. North America Peptide Therapeutics Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Peptide Therapeutics Market: By Technology, 2022-2032, USD (Million)
8.3. Peptide Therapeutics Market: By Delivery Route, 2022-2032, USD (Million)
8.4. Peptide Therapeutics Market: By Applications, 2022-2032, USD (Million)
8.5.Peptide Therapeutics Market: By Region, 2022-2032, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Peptide Therapeutics Market: By Technology, 2022-2032, USD (Million)
8.5.1.1.2. Peptide Therapeutics Market: By Delivery Route, 2022-2032, USD (Million)
8.5.1.1.3. Peptide Therapeutics Market: By Applications, 2022-2032, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Peptide Therapeutics Market: By Technology, 2022-2032, USD (Million)
8.5.1.2.2. Peptide Therapeutics Market: By Delivery Route, 2022-2032, USD (Million)
8.5.1.2.3. Peptide Therapeutics Market: By Applications, 2022-2032, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Peptide Therapeutics Market: By Technology, 2022-2032, USD (Million)
8.5.1.3.2. Peptide Therapeutics Market: By Delivery Route, 2022-2032, USD (Million)
8.5.1.3.3. Peptide Therapeutics Market: By Applications, 2022-2032, USD (Million)
9. UK and European Union Peptide Therapeutics Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Peptide Therapeutics Market: By Technology, 2022-2032, USD (Million)
9.3. Peptide Therapeutics Market: By Delivery Route, 2022-2032, USD (Million)
9.4. Peptide Therapeutics Market: By Applications, 2022-2032, USD (Million)
9.5.Peptide Therapeutics Market: By Region, 2022-2032, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Peptide Therapeutics Market: By Technology, 2022-2032, USD (Million)
9.5.1.1.2. Peptide Therapeutics Market: By Delivery Route, 2022-2032, USD (Million)
9.5.1.1.3. Peptide Therapeutics Market: By Applications, 2022-2032, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Peptide Therapeutics Market: By Technology, 2022-2032, USD (Million)
9.5.1.2.2. Peptide Therapeutics Market: By Delivery Route, 2022-2032, USD (Million)
9.5.1.2.3. Peptide Therapeutics Market: By Applications, 2022-2032, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Peptide Therapeutics Market: By Technology, 2022-2032, USD (Million)
9.5.1.3.2. Peptide Therapeutics Market: By Delivery Route, 2022-2032, USD (Million)
9.5.1.3.3. Peptide Therapeutics Market: By Applications, 2022-2032, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Peptide Therapeutics Market: By Technology, 2022-2032, USD (Million)
9.5.1.4.2. Peptide Therapeutics Market: By Delivery Route, 2022-2032, USD (Million)
9.5.1.4.3. Peptide Therapeutics Market: By Applications, 2022-2032, USD (Million)
9.5.1.5. France
9.5.1.5.1. Peptide Therapeutics Market: By Technology, 2022-2032, USD (Million)
9.5.1.5.2. Peptide Therapeutics Market: By Delivery Route, 2022-2032, USD (Million)
9.5.1.5.3. Peptide Therapeutics Market: By Applications, 2022-2032, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Peptide Therapeutics Market: By Technology, 2022-2032, USD (Million)
9.5.1.6.2. Peptide Therapeutics Market: By Delivery Route, 2022-2032, USD (Million)
9.5.1.6.3. Peptide Therapeutics Market: By Applications, 2022-2032, USD (Million)
10. Asia Pacific Peptide Therapeutics Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Peptide Therapeutics Market: By Technology, 2022-2032, USD (Million)
10.3. Peptide Therapeutics Market: By Delivery Route, 2022-2032, USD (Million)
10.4. Peptide Therapeutics Market: By Applications, 2022-2032, USD (Million)
10.5.Peptide Therapeutics Market: By Region, 2022-2032, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Peptide Therapeutics Market: By Technology, 2022-2032, USD (Million)
10.5.1.1.2. Peptide Therapeutics Market: By Delivery Route, 2022-2032, USD (Million)
10.5.1.1.3. Peptide Therapeutics Market: By Applications, 2022-2032, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Peptide Therapeutics Market: By Technology, 2022-2032, USD (Million)
10.5.1.2.2. Peptide Therapeutics Market: By Delivery Route, 2022-2032, USD (Million)
10.5.1.2.3. Peptide Therapeutics Market: By Applications, 2022-2032, USD (Million)
10.5.1.3. India
10.5.1.3.1. Peptide Therapeutics Market: By Technology, 2022-2032, USD (Million)
10.5.1.3.2. Peptide Therapeutics Market: By Delivery Route, 2022-2032, USD (Million)
10.5.1.3.3. Peptide Therapeutics Market: By Applications, 2022-2032, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Peptide Therapeutics Market: By Technology, 2022-2032, USD (Million)
10.5.1.4.2. Peptide Therapeutics Market: By Delivery Route, 2022-2032, USD (Million)
10.5.1.4.3. Peptide Therapeutics Market: By Applications, 2022-2032, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Peptide Therapeutics Market: By Technology, 2022-2032, USD (Million)
10.5.1.5.2. Peptide Therapeutics Market: By Delivery Route, 2022-2032, USD (Million)
10.5.1.5.3. Peptide Therapeutics Market: By Applications, 2022-2032, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Peptide Therapeutics Market: By Technology, 2022-2032, USD (Million)
10.5.1.6.2. Peptide Therapeutics Market: By Delivery Route, 2022-2032, USD (Million)
10.5.1.6.3. Peptide Therapeutics Market: By Applications, 2022-2032, USD (Million)
11. Latin America Peptide Therapeutics Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Peptide Therapeutics Market: By Technology, 2022-2032, USD (Million)
11.3. Peptide Therapeutics Market: By Delivery Route, 2022-2032, USD (Million)
11.4. Peptide Therapeutics Market: By Applications, 2022-2032, USD (Million)
11.5.Peptide Therapeutics Market: By Region, 2022-2032, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Peptide Therapeutics Market: By Technology, 2022-2032, USD (Million)
11.5.1.1.2. Peptide Therapeutics Market: By Delivery Route, 2022-2032, USD (Million)
11.5.1.1.3. Peptide Therapeutics Market: By Applications, 2022-2032, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Peptide Therapeutics Market: By Technology, 2022-2032, USD (Million)
11.5.1.2.2. Peptide Therapeutics Market: By Delivery Route, 2022-2032, USD (Million)
11.5.1.2.3. Peptide Therapeutics Market: By Applications, 2022-2032, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Peptide Therapeutics Market: By Technology, 2022-2032, USD (Million)
11.5.1.3.2. Peptide Therapeutics Market: By Delivery Route, 2022-2032, USD (Million)
11.5.1.3.3. Peptide Therapeutics Market: By Applications, 2022-2032, USD (Million)
12. Middle East and Africa Peptide Therapeutics Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Peptide Therapeutics Market: By Technology, 2022-2032, USD (Million)
12.3. Peptide Therapeutics Market: By Delivery Route, 2022-2032, USD (Million)
12.4. Peptide Therapeutics Market: By Applications, 2022-2032, USD (Million)
12.5.Peptide Therapeutics Market: By Region, 2022-2032, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Peptide Therapeutics Market: By Technology, 2022-2032, USD (Million)
12.5.1.1.2. Peptide Therapeutics Market: By Delivery Route, 2022-2032, USD (Million)
12.5.1.1.3. Peptide Therapeutics Market: By Applications, 2022-2032, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Peptide Therapeutics Market: By Technology, 2022-2032, USD (Million)
12.5.1.2.2. Peptide Therapeutics Market: By Delivery Route, 2022-2032, USD (Million)
12.5.1.2.3. Peptide Therapeutics Market: By Applications, 2022-2032, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Peptide Therapeutics Market: By Technology, 2022-2032, USD (Million)
12.5.1.3.2. Peptide Therapeutics Market: By Delivery Route, 2022-2032, USD (Million)
12.5.1.3.3. Peptide Therapeutics Market: By Applications, 2022-2032, USD (Million)
13. Company Profile
13.1. Amgen Inc.
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. Amylin Pharmaceuticals LLC (Bristol- Myers Squibb)
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. AstraZeneca plc
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. Bachem Holding AG
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. Eli Lilly and Company
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. GlaxoSmithKline plc
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. Ipsen
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. Lonza, Inc.
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives
13.9. Merck & Co.
13.9.1. Company Overview
13.9.2. Financial Performance
13.9.3. Product Portfolio
13.9.4. Strategic Initiatives
13.10. Novartis AG
13.10.1. Company Overview
13.10.2. Financial Performance
13.10.3. Product Portfolio
13.10.4. Strategic Initiatives
13.11. Novo- Nordisk A/S
13.11.1. Company Overview
13.11.2. Financial Performance
13.11.3. Product Portfolio
13.11.4. Strategic Initiatives
13.12. Peptisyntha
13.12.1. Company Overview
13.12.2. Financial Performance
13.12.3. Product Portfolio
13.12.4. Strategic Initiatives
13.13. PolyPeptide Group
13.13.1. Company Overview
13.13.2. Financial Performance
13.13.3. Product Portfolio
13.13.4. Strategic Initiatives
13.14. Pfizer, Inc.
13.14.1. Company Overview
13.14.2. Financial Performance
13.14.3. Product Portfolio
13.14.4. Strategic Initiatives
13.15. F. Hoffman-La Roche AG
13.15.1. Company Overview
13.15.2. Financial Performance
13.15.3. Product Portfolio
13.15.4. Strategic Initiatives
13.16. Sanofi S.A.
13.16.1. Company Overview
13.16.2. Financial Performance
13.16.3. Product Portfolio
13.16.4. Strategic Initiatives
13.17. Takeda Pharmaceutical Company Limited
13.17.1. Company Overview
13.17.2. Financial Performance
13.17.3. Product Portfolio
13.17.4. Strategic Initiatives
13.18. Teva Pharmaceuticals
13.18.1. Company Overview
13.18.2. Financial Performance
13.18.3. Product Portfolio
13.18.4. Strategic Initiatives
Choose Licence Type
Single User Licence
$4325
Multi User license
$6325
Corporate license
$12650
Buy Now
Quick Contact
+1-855-455-8662
+91 77559-81103
sales@acutemarketreports.com
View Other Reports
Automotive
986
Chemicals and Materials
684
Consumer Goods
184
Energy
124
Food & Beverages
321
Medical Devices
178
Pharmaceutical & Healthcare
78
Technology
234